Reversal of ampicillin resistance in MRSA via inhibition of penicillin-binding protein 2a by Acalypha wilkesiana

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Santiago, Carolina ^a   Pang, Ee Leen ^a   Lim, Kuan Hon ^a   Loh, Hwei San ^a   Ting, Kang Nee ^a  

^a UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

9EA FC B; AMPICILLIN; ANTIBIOTIC AGENT; CORILAGIN; PENICILLIN BINDING PROTEIN 2A; PLANT EXTRACT; UNCLASSIFIED DRUG; PENICILLIN BINDING PROTEIN; PENICILLIN-BINDING PROTEIN 2A, STREPTOCOCCUS; PEPTIDE SYNTHASE;

ACALYPHA WILKESIANA; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG POTENTIATION; FRACTIONAL INHIBITORY CONCENTRATION; GROWTH CURVE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PHARMACOLOGICAL PARAMETERS; PROTEIN EXPRESSION; WESTERN BLOTTING; ACALYPHA; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS;

ACALYPHA; AMPICILLIN; AMPICILLIN RESISTANCE; DRUG SYNERGISM; GENE EXPRESSION REGULATION, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN-BINDING PROTEINS; PEPTIDE SYNTHASES; PLANT EXTRACTS;

EID: 84904797027     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/965348     Document Type: Article

References (35)

1. Snider J., Rapids M., Rivard B., Methicillin-resistant Staphylococcus aureus: a review of current antibiotic therapy. Spectrum Health Grand Rapids 2012
2. Gillespie M. T., May J. W., Skurray R. A., Antibiotic resistance in Staphylococcus aureus isolated at an Australian hospital between 1946 and 1981. Journal of Medical Microbiology 1985 19 2 137 147 10.1099/00222615-19-2-137 2-s2.0-0021886329 (Pubitemid 15086837)
3. Berger-Bächi B., Rohrer S., Factors influencing methicillin resistance in staphylococci. Archives of Microbiology 2002 178 3 165 171 10.1007/s00203-002-0436-0 2-s2.0-0036367233 (Pubitemid 34985297)
4. Berger-Bächi B., Expression of resistance to methicillin. Trends in Microbiology 1994 2 10 389 393 10.1016/0966-842X(94)90617-3 2-s2.0-0027948397 (Pubitemid 24320451)
5. Vouillamoz J., Entenza J. M., Hohl P., Moreillon P., LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2004 48 11 4322 4327 10.1128/AAC.48.11.4322-4327.2004 2-s2.0-7244247147 (Pubitemid 39434893)
6. Hemaiswarya S., Kruthiventi A. K., Doble M., Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008 15 8 639 652 10.1016/j.phymed.2008.06.008 2-s2.0-46049087489
7. Shimizu M., Shiota S., Mizushima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., Marked potentiation of activity of β -lactams against methicillin-resistant Staphylococcus aureus by corilagin. Antimicrobial Agents and Chemotherapy 2001 45 11 3198 3201 10.1128/AAC.45.11.3198-3201.2001 2-s2.0-0034780297 (Pubitemid 32988850)
8. Alade P. I., Irobi O. N., Antimicrobial activities of crude leaf extracts of Acalypha wilkesiana. Journal of Ethnopharmacology 1993 39 3 171 174 10.1016/0378-8741(93)90033-2 2-s2.0-0027295948 (Pubitemid 23272433)
9. Akinde B. E., Odeyemi O. O., Extraction and microbiological evaluation of the oils from the leaves of Acalypha wilkesiana. Nigerian Medical Journal 1987 17 163 165
10. Lim S. W., Ting K. N., Bradshaw T. D., Zeenathul N. A., Wiart C., Khoo T. J., Lim K. H., Loh H. S., Acalypha wilkesiana extracts induce apoptosis by causing single strand and double strand DNA breaks. Journal of Ethnopharmacology 2011 138 2 616 623 10.1016/j.jep.2011.10.005 2-s2.0-81255208503
11. Lim S. W., Loh H. S., Ting K. N., Bradshaw T. D., Zeenathul N. A., Acalypha wilkesiana ethyl acetate extract enhances the in vitro cytotoxic effects of α -tocopherol in human brain and lung cancer cells. International Journal of Bioscience, Biochemistry and Bioinformatics 2013 3 4 335 340
12. Othman M., Genapathy S., Liew P. S., Chng Q. T., Loh H. S., Khoo T. J., Wiart C., Ting K. N., Search for antibacterial agents from Malaysian rainforest and tropical plants. Natural Product Research 2011 25 19 1857 1864 10.1080/14786419.2010.537274 2-s2.0-84857207949
13. Spigno G., de Faveri D. M., Antioxidants from grape stalks and marc: influence of extraction procedure on yield, purity and antioxidant power of the extracts. Journal of Food Engineering 2007 78 3 793 801 10.1016/j.jfoodeng.2005. 11.020 2-s2.0-33846627942
14. Othman M., Loh H. S., Wiart C., Khoo T. J., Lim K. H., Ting K. N., Optimal methods for evaluating antimicrobial activities from plant extracts. Journal of Microbiological Methods 2011 84 2 161 166 10.1016/j.mimet.2010.11.008 2-s2.0-79251640333
15. Clinical and Laboratory Standards Institute (CLSI), Laboratory methods for detection of methicillin-resistant Staphylococcus aureus (MRSA). Supplement M100-S17, 2007
16. Andrews J. M., Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy 2001 48 1 5 16 10.1093/jac/48.suppl-1.5 2-s2.0-0034924241
17. Brown D. F. J., Detection of methicillin/oxacillin resistance in staphylococci. Journal of Antimicrobial Chemotherapy 2001 48 1 65 70 10.1093/jac/48.suppl-1.65 2-s2.0-0034915756
18. Cos P., Vlietinck A. J., Berghe D. V., Maes L., Anti-infective potential of natural products: how to develop a stronger in vitro proof-of-concept. Journal of Ethnopharmacology 2006 106 3 290 302 10.1016/j.jep.2006.04.003 2-s2.0-33745435902 (Pubitemid 43949328)
19. White R. L., Burgess D. S., Manduru M., Bosso J. A., Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrobial Agents and Chemotherapy 1996 40 8 1914 1918 2-s2.0-0029800028 (Pubitemid 26277815)
20. U.S Food and Drug Administration (FDA), CDER New Molecular Entity (NME) Drug and New Biologic Approvals in Calendar Year 2006
21. Schmitz F. J., Fluit A. C., Lückefahr M., Engler B., Hofmann B., Verhoef J., Heinz H., Hadding U., Jones M. E., The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 1998 42 6 807 810 10.1093/jac/42.6.807 2-s2.0-0032445682 (Pubitemid 29008084)
22. Stermitz F. R., Lorenz P., Tawara J. N., Zenewicz L. A., Lewis K., Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1433 1437 10.1073/pnas.030540597 2-s2.0-0034652383 (Pubitemid 30118458)
23. Cho Y., Schiller N. L., Oh K., Antibacterial effects of green tea polyphenols on clinical isolates of methicillin-resistant Staphylococcus aureus. Current Microbiology 2008 57 6 542 546 10.1007/s00284-008-9239-0 2-s2.0-56949099579 (Pubitemid 50266360)
24. Shiota S., Shimizu M., Sugiyama J., Morita Y., Mizushima T., Tsuchiya T., Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of β -lactams against methicillin-resistant Staphylococcus aureus. Microbiology and Immunology 2004 48 1 67 73 10.1111/j.1348-0421.2004.tb03489.x 2-s2.0-0942297805 (Pubitemid 38141245)
25. Dukan S., Nyström T., Bacterial senescence: stasis results in increased and differential oxidation of cytoplasmic proteins leading to developmental induction of the heat shock regulon. Genes & Development 1998 12 21 3431 3441 10.1101/gad.12.21.3431 2-s2.0-0032213238 (Pubitemid 28520990)
26. Venezia R. A., Domaracki B. E., Evans A. M., Preston K. E., Graffunder E. M., Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. Journal of Antimicrobial Chemotherapy 2001 48 3 375 381 10.1093/jac/48.3.375 2-s2.0-0034801620 (Pubitemid 32898808)
27. Navarro Llorens J. M., Tormo A., Martínez-García E., Stationary phase in gram-negative bacteria. FEMS Microbiology Reviews 2010 34 4 476 495 10.1111/j.1574-6976.2010.00213.x 2-s2.0-77953206924
28. Rolfe M. D., Rice C. J., Lucchini S., Pin C., Thompson A., Cameron A. D. S., Alston M., Stringer M. F., Betts R. P., Baranyi J., Peck M. W., Hinton J. C. D., Lag phase is a distinct growth phase that prepares bacteria for exponential growth and involves transient metal accumulation. Journal of Bacteriology 2011 194 3 686 701 10.1128/JB.06112-11 2-s2.0-84855928763
29. Lambert P., Denyer S. P., Hodges N. A., Gorman S. P., Mechanism of action of antibiotics and synthethic anti-infective agents. Hugo and Russell's Pharmaceutical Microbiology 2004 7th Oxford, UK Blackwell Publishing 202 206
30. Smith A., Denyer S. P., Hodges N. A., Gorman S. P., Bacterial resistance to antibiotics. Hugo and Russell's Pharmaceutical Microbiology 2004 7th Oxford, UK Blackwell 220 223
31. Chambers H. F., Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clinical Microbiology Reviews 1997 10 4 781 791 2-s2.0-0030681046 (Pubitemid 27477734)
32. Archer G. L., Bosilevac J. M., Signaling antibiotic resistance in staphylococci. Science 2001 291 5510 1915 1916 10.1126/science.1059671 2-s2.0-0035831257 (Pubitemid 32216984)
33. Zhang H. Z., Hackbarth C. J., Chansky K. M., Chambers H. F., A proteolytic transmembrane signaling pathway and resistance to β -lactams in Staphylococci. Science 2001 291 5510 1962 1965 10.1126/science.1055144 2-s2.0-0035831262 (Pubitemid 32216996)
34. Deresinski S., Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clinical Infectious Diseases 2005 40 4 562 573 10.1086/427701 2-s2.0-13944274479 (Pubitemid 40270226)
35. Din W. M., Chu J., Clarke G., Jin K. T., Bradshaw T. D., Fry J. R., Wiart C., Antioxidant and cytoprotective effects of an ethanol extract of Acalypha wilkesiana var. macafeana from Malaysia. Natural Product Communications 2013 8 3 375 380 2-s2.0-84875768287